Vir Biotechnology, Inc. (NASDAQ:VIR) Receives $35.67 Average Price Target from Analysts
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price […]
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price […]
